title: Pilot study of the combination of melphalan, carboplatin and etoposide as a conditioning regimen for relapsed lymphoma patients.
authors.affiliation: ABC Foundation School of Medicine, São Paulo, Brazil. sandrabr@netpoint.com.br
authors.forename: A
authors.initials: A
authors.lastname: del Giglio
authors.forename: L J
authors.initials: LJ
authors.lastname: Costa
authors.forename: H
authors.initials: H
authors.lastname: Pinczowski
authors.forename: P C
authors.initials: PC
authors.lastname: Varella
authors.forename: J R
authors.initials: JR
authors.lastname: Luzzi
authors.forename: P
authors.initials: P
authors.lastname: Neves
authors.forename: A
authors.initials: A
authors.lastname: Mota
authors.forename: P
authors.initials: P
authors.lastname: Boente
authors.forename: C
authors.initials: C
authors.lastname: Sampaio
mesh_terms: D000293:Adolescent; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D005047:Etoposide / Q000008:administration & dosage; D018380:Hematopoietic Stem Cell Transplantation; D006689:Hodgkin Disease / Q000628:therapy*; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*; D008558:Melphalan / Q000008:administration & dosage; D008875:Middle Aged; D010865:Pilot Projects; D012008:Recurrence; D019172:Transplantation Conditioning
chemical_list: D000970:Antineoplastic Agents; D005047:Etoposide; D016190:Carboplatin; D008558:Melphalan